Last update 08 May 2025

COVID-2019 DNA vaccine (Immuno Cure 3)

Overview

Basic Info

Drug Type
DNA vaccine, Prophylactic vaccine
Synonyms
SARSCoV2 DNA Vaccine (Immuno Cure 3)
Target-
Action
stimulants
Mechanism
Immunostimulants
Therapeutic Areas
Infectious DiseasesRespiratory Diseases
Active Indication
COVID-19
Inactive Indication
Severe Acute Respiratory Syndrome
Originator Organization
The University of Hong KongThe University of Hong Kong
Active Organization
The University of Hong KongThe University of Hong Kong
Inactive Organization
Immuno Cure 3 Limited
License Organization-
Drug Highest PhasePreclinical
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with COVID-2019 DNA vaccine (Immuno Cure 3)
NCT05102643
/ Unknown statusPhase 1
A Phase 1, Randomized, Double-blinded, Placebo-controlled, Dose-escalation Study to Evaluate the Safety and Immunogenicity of SARS-CoV-2 DNA Vaccine Delivered Intramuscularly Followed by Electroporation for COVID-19 in Healthy Adults
100 Clinical Results associated with COVID-2019 DNA vaccine (Immuno Cure 3)
Login to view more data
100 Translational Medicine associated with COVID-2019 DNA vaccine (Immuno Cure 3)
Login to view more data
100 Patents (Medical) associated with COVID-2019 DNA vaccine (Immuno Cure 3)
Login to view more data
100 Deals associated with COVID-2019 DNA vaccine (Immuno Cure 3)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
COVID-19Preclinical
Hong Kong
Immuno Cure 3 Limited
18 Nov 2021
Severe Acute Respiratory SyndromePreclinical
Hong Kong
Immuno Cure 3 Limited
18 Nov 2021
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free